miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes

2013353 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Diabetologia

Volume 56, Issue 3, pp. 663-674

Field-Weighted Citation Impact: 13.27